Johannes Schwenke is an MD-PhD student in the research group of Prof. Briel. During his MD-PhD, he is implementing and coordinating the LIQPLAT trial, which investigates the routine use of circulating tumor DNA in patients with advanced cancers at the Department of Medical Oncology of the University Hospital Basel.